Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics study.

Zeidan B, Manousopoulou A, Garay-Baquero DJ, White CH, Larkin SET, Potter KN, Roumeliotis TI, Papachristou EK, Copson E, Cutress RI, Beers SA, Eccles D, Townsend PA, Garbis SD.

Breast Cancer Res. 2018 Mar 22;20(1):19. doi: 10.1186/s13058-018-0938-6.

2.

Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Hargreaves CE, Iriyama C, Rose-Zerilli MJ, Nagelkerke SQ, Hussain K, Ganderton R, Lee C, Machado LR, Hollox EJ, Parker H, Latham KV, Kuijpers TW, Potter KN, Coupland SE, Davies A, Stackpole M, Oates M, Pettitt AR, Glennie MJ, Cragg MS, Strefford JC.

PLoS One. 2016 Mar 23;11(3):e0145040. doi: 10.1371/journal.pone.0145040. eCollection 2016. No abstract available.

3.

Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Hargreaves CE, Iriyama C, Rose-Zerilli MJ, Nagelkerke SQ, Hussain K, Ganderton R, Lee C, Machado LR, Hollox EJ, Parker H, Latham KV, Kuijpers TW, Potter KN, Coupland SE, Davies A, Stackpole M, Oates M, Pettitt AR, Glennie MJ, Cragg MS, Strefford JC.

PLoS One. 2015 Nov 6;10(11):e0142379. doi: 10.1371/journal.pone.0142379. eCollection 2015. Erratum in: PLoS One. 2016;11(3):e0145040.

4.

Stimulation of surface IgM of chronic lymphocytic leukemia cells induces an unfolded protein response dependent on BTK and SYK.

Krysov S, Steele AJ, Coelho V, Linley A, Sanchez Hidalgo M, Carter M, Potter KN, Kennedy B, Duncombe AS, Ashton-Key M, Forconi F, Stevenson FK, Packham G.

Blood. 2014 Nov 13;124(20):3101-9. doi: 10.1182/blood-2014-04-567198. Epub 2014 Aug 28.

5.

A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma.

Horvilleur E, Sbarrato T, Hill K, Spriggs RV, Screen M, Goodrem PJ, Sawicka K, Chaplin LC, Touriol C, Packham G, Potter KN, Dirnhofer S, Tzankov A, Dyer MJ, Bushell M, MacFarlane M, Willis AE.

Leukemia. 2014 May;28(5):1092-102. doi: 10.1038/leu.2013.295. Epub 2013 Oct 18.

6.

The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.

Forconi F, Potter KN, Sozzi E, Henderson I, Cencini E, Rossi D, Bomben R, Gattei V, Gaidano G, Packham G, Stevenson FK.

Blood. 2012 Mar 1;119(9):2106-9. doi: 10.1182/blood-2011-08-375501. Epub 2012 Jan 10.

PMID:
22234701
7.

Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia.

Paterson A, Mockridge CI, Adams JE, Krysov S, Potter KN, Duncombe AS, Cook SJ, Stevenson FK, Packham G.

Blood. 2012 Feb 16;119(7):1726-36. doi: 10.1182/blood-2011-07-367417. Epub 2011 Dec 7.

PMID:
22160382
8.

Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells.

Krysov S, Dias S, Paterson A, Mockridge CI, Potter KN, Smith KA, Ashton-Key M, Stevenson FK, Packham G.

Blood. 2012 Jan 5;119(1):170-9. doi: 10.1182/blood-2011-07-370403. Epub 2011 Nov 15.

PMID:
22086413
9.

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy.

Lim SH, Vaughan AT, Ashton-Key M, Williams EL, Dixon SV, Chan HT, Beers SA, French RR, Cox KL, Davies AJ, Potter KN, Mockridge CI, Oscier DG, Johnson PW, Cragg MS, Glennie MJ.

Blood. 2011 Sep 1;118(9):2530-40. doi: 10.1182/blood-2011-01-330357. Epub 2011 Jul 18.

PMID:
21768293
10.

Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases.

Langerak AW, Davi F, Ghia P, Hadzidimitriou A, Murray F, Potter KN, Rosenquist R, Stamatopoulos K, Belessi C; European Research Initiative on CLL (ERIC).

Leukemia. 2011 Jun;25(6):979-84. doi: 10.1038/leu.2011.49. Epub 2011 Apr 1.

PMID:
21455216
11.

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins.

Coelho V, Krysov S, Ghaemmaghami AM, Emara M, Potter KN, Johnson P, Packham G, Martinez-Pomares L, Stevenson FK.

Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18587-92. doi: 10.1073/pnas.1009388107. Epub 2010 Oct 11.

12.

Surface IgM of CLL cells displays unusual glycans indicative of engagement of antigen in vivo.

Krysov S, Potter KN, Mockridge CI, Coelho V, Wheatley I, Packham G, Stevenson FK.

Blood. 2010 May 27;115(21):4198-205. doi: 10.1182/blood-2009-12-254847. Epub 2010 Mar 17.

PMID:
20237321
13.

The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL.

Forconi F, Potter KN, Wheatley I, Darzentas N, Sozzi E, Stamatopoulos K, Mockridge CI, Packham G, Stevenson FK.

Blood. 2010 Jan 7;115(1):71-7. doi: 10.1182/blood-2009-06-225813. Epub 2009 Nov 3.

PMID:
19887677
14.

Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.

Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL, Potter KN, Murray S, Chan CH, Klymenko T, Erenpreisa J, Glennie MJ, Illidge TM, Cragg MS.

J Clin Invest. 2009 Aug;119(8):2143-59. doi: 10.1172/JCI37884. Epub 2009 Jul 20.

15.

Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status.

Mockridge CI, Potter KN, Wheatley I, Neville LA, Packham G, Stevenson FK.

Blood. 2007 May 15;109(10):4424-31. Epub 2007 Jan 25.

PMID:
17255355
16.

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.

Radcliffe CM, Arnold JN, Suter DM, Wormald MR, Harvey DJ, Royle L, Mimura Y, Kimura Y, Sim RB, Inogès S, Rodriguez-Calvillo M, Zabalegui N, de Cerio AL, Potter KN, Mockridge CI, Dwek RA, Bendandi M, Rudd PM, Stevenson FK.

J Biol Chem. 2007 Mar 9;282(10):7405-15. Epub 2006 Dec 29.

17.

Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.

Pickering BM, de Mel S, Lee M, Howell M, Habens F, Dallman CL, Neville LA, Potter KN, Mann J, Mann DA, Johnson PW, Stevenson FK, Packham G.

Oncogene. 2007 Feb 22;26(8):1166-77. Epub 2006 Aug 21.

PMID:
16924235
18.

Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.

Potter KN, Mockridge CI, Neville L, Wheatley I, Schenk M, Orchard J, Duncombe AS, Packham G, Stevenson FK.

Clin Cancer Res. 2006 Mar 15;12(6):1672-9.

19.

Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.

McWhirter JR, Kretz-Rommel A, Saven A, Maruyama T, Potter KN, Mockridge CI, Ravey EP, Qin F, Bowdish KS.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1041-6. Epub 2006 Jan 17.

20.

The relevance of sequence insertions in the Mcl-1 promoter in chronic lymphocytic leukemia and in normal cells.

Coenen S, Pickering B, Potter KN, Johnson PW, Stevenson FK, Packham G.

Haematologica. 2005 Sep;90(9):1285-6.

21.

Common patterns of B cell perturbation and expanded V4-34 immunoglobulin gene usage in autoimmunity and infection.

Mockridge CI, Rahman A, Buchan S, Hamblin T, Isenberg DA, Stevenson FK, Potter KN.

Autoimmunity. 2004 Feb;37(1):9-15.

PMID:
15115306
22.

Disturbances in peripheral blood B cell subpopulations in autoimmune patients.

Potter KN, Mockridge CI, Rahman A, Buchan S, Hamblin T, Davidson B, Isenberg DA, Stevenson FK.

Lupus. 2002;11(12):872-7. Review.

PMID:
12529053
23.

Anti-DNA antibodies--structure and function.

Rahman A, Kumar S, Potter KN.

Lupus. 2002;11(12):776-9. Review.

PMID:
12529038
24.

Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire.

Potter KN, Orchard J, Critchley E, Mockridge CI, Jose A, Stevenson FK.

Blood. 2003 Apr 15;101(8):3082-4. Epub 2002 Dec 12.

PMID:
12480699
25.
26.

Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis.

Potter KN, Thomson RK, Hamblin A, Richards SD, Lindsay JG, Stevenson FK.

J Mol Biol. 2001 Feb 9;306(1):37-46.

PMID:
11178892
27.

The molecular specificity of insulin autoantibodies.

Potter KN, Wilkin TJ.

Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):338-53. Review.

PMID:
11025558
28.

Molecular characterization of cold agglutinins.

Potter KN.

Transfus Sci. 2000 Feb-Apr;22(1-2):113-9. Review.

PMID:
10771399
30.

Learning-related fos-like immunoreactivity in the chick brain: time-course and co-localization with GABA and parvalbumin.

Ambalavanar R, McCabe BJ, Potter KN, Horn G.

Neuroscience. 1999;93(4):1515-24.

PMID:
10501476
31.

A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1.

Thomas MD, Clough K, Melamed MD, Stevenson FK, Chapman CJ, Spellerberg MB, Potter KN, Newton-Bishop JA, Gregson N, Dawson K.

Hum Antibodies. 1999;9(2):95-106.

PMID:
10405830
32.
33.
34.

Staphylococcal protein A binding to VH3 encoded immunoglobulins.

Potter KN, Li Y, Pascual V, Capra JD.

Int Rev Immunol. 1997;14(4):291-308. Review.

PMID:
9186782
35.

The MoAb-V kappa IIIb cross-reactive idiotope on A27a (Humkv325) encoded kappa chains maps to framework region 3. off.

Potter KN, Li YC, Abraham GN, Capra JD.

Scand J Immunol. 1996 Oct;44(4):305-13.

PMID:
8845022
37.
39.

Complementarity-determining region 2 is implicated in the binding of staphylococcal protein A to human immunoglobulin VHIII variable regions.

Randen I, Potter KN, Li Y, Thompson KM, Pascual V, Førre O, Natvig JB, Capra JD.

Eur J Immunol. 1993 Oct;23(10):2682-6.

PMID:
8405066
40.

Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segment.

Potter KN, Li Y, Pascual V, Williams RC Jr, Byres LC, Spellerberg M, Stevenson FK, Capra JD.

J Exp Med. 1993 Oct 1;178(4):1419-28.

41.

Antibody production in the baculovirus expression system.

Potter KN, Li Y, Capra JD.

Int Rev Immunol. 1993;10(2-3):103-12. Review.

PMID:
8360578
42.
43.

Methylation blockage and other improvements to a comprehensive DNA analysis program.

Stone TW, Potter KN.

Nucleic Acids Res. 1986 Jan 10;14(1):255-64.

44.
45.

Modification of Trichoplusia ni nuclear polyhedrosis virus passaged in vivo.

Potter KN, Jaques RP, Faulkner P.

Intervirology. 1978;9(2):76-85.

PMID:
338547
46.
47.

Strain selection during serial passage of Trichoplusia in nuclear polyhedrosis virus.

Potter KN, Faulkner P, MacKinnon EA.

J Virol. 1976 Jun;18(3):1040-50.

Supplemental Content

Loading ...
Support Center